Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis.
<h4>Background</h4>Albendazole is an orally administered anti-parasitic medication with widespread usage in a variety of both programmatic and clinical contexts. Previous work has shown that the drug's pharmacologically active metabolite, albendazole sulfoxide, is characterised by s...
Saved in:
Main Authors: | Charles Whittaker (Author), Cédric B Chesnais (Author), Sébastien D S Pion (Author), Joseph Kamgno (Author), Martin Walker (Author), Maria-Gloria Basáñez (Author), Michel Boussinesq (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
by: Sébastien D S Pion, et al.
Published: (2020) -
The efficacy of single-dose albendazole for the treatment of ascariasis
by: Deddy S Putra, et al.
Published: (2016) -
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World.
by: Jérémy T Campillo, et al.
Published: (2021) -
Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.
by: Christoph Kaiser, et al.
Published: (2013) -
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
by: Yashpal S Chhonker, et al.
Published: (2023)